Furthermore, urotensin II acts synergistically with the renin–angiotensin system, itself a major contributor to the progression of CKD (Takahashi et al., 2009), to stimulate fibrosis (Song et al., 2012) and contraction of the thoracic aorta (Wang et al., 2007). This evidence concerns the gene UTS2 and chronic kidney disease.